← Back to Blog

Does Ginseng Reduce Inflammation? What the Evidence Shows

Ginseng is one of the most heavily used herbal remedies in the world, prized for centuries as a tonic for energy and resilience. The modern question is narrower and more testable: do its active compounds actually calm inflammation, and does that show up in a marker like CRP?

Written by Sydney Murphy, CMO & Digital Products Officer. Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.

The short answer

Partly, and it depends on which marker you look at. Ginseng contains active compounds called ginsenosides that suppress inflammatory signaling in laboratory and animal studies, and human trials back part of this up. A 2019 meta-analysis of seven randomized controlled trials found that ginseng supplementation significantly lowered interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) but did not significantly change C-reactive protein (CRP) overall. A separate meta-analysis found ginseng reduced CRP mainly in people who started with elevated levels. So ginseng appears to nudge inflammation down, but its effect on CRP specifically is modest and most visible in people whose inflammation is already high.

Ginseng is among the oldest and most widely studied botanicals in traditional medicine. The name usually refers to plants in the genus Panax, a word that shares a root with "panacea," reflecting the sweeping reputation ginseng carried for thousands of years as a cure-all tonic. Today the science is more sober and more specific. Researchers have isolated the compounds responsible for most of ginseng's biological activity, mapped the signaling pathways they act on, and run controlled trials to see whether the ancient claims hold up when measured against placebo. Inflammation is one of the areas where that modern evidence is strongest, though as with most supplements the real story is more nuanced than either the marketing or the skepticism suggests.

Ginseng refers to the fleshy roots of several Panax species, most commonly Asian or Korean ginseng (Panax ginseng) and American ginseng (Panax quinquefolius). Its principal active compounds are ginsenosides, a family of steroid-like molecules also called saponins. When ginseng is steamed and dried to make "red ginseng," the profile of these ginsenosides shifts, which is part of why different ginseng products can behave differently in the body.

How Ginseng Fights Inflammation

Ginseng's anti-inflammatory activity is driven almost entirely by its ginsenosides, which interfere with the master inflammatory switch NF-kB. Nuclear factor kappa B (NF-kB) is a protein complex that sits at the center of the inflammatory response. When it is activated, it moves into the cell nucleus and turns on the genes that produce pro-inflammatory messengers such as TNF-alpha, IL-6, and IL-1beta. According to a 2023 review of ginsenoside mechanisms in Anti-Cancer Agents in Medicinal Chemistry, individual ginsenosides suppress NF-kB activation along with related signaling pathways including p38 MAPK, JNK, and the Jak2/Stat3 cascade, reducing the output of those inflammatory cytokines (Jung et al., 2023). In practical terms, ginseng appears to turn down the volume on the signaling that starts an inflammatory response rather than simply mopping up its byproducts.

Different ginsenosides appear to specialize, which helps explain why whole-root ginseng has broad effects. Ginseng roots contain dozens of distinct ginsenosides, labeled with codes like Rb1, Rg1, Rg3, and Rh2, and laboratory work shows they are not interchangeable. Some are stronger inhibitors of NF-kB, others act more on the enzymes that generate reactive oxygen species, and still others influence the balance of immune cell populations. This diversity is a double-edged sword for research. It gives ginseng a wide range of biological activity, but it also means that two ginseng products with different ginsenoside profiles can produce different results, making the human trial literature harder to compare than it is for a single purified molecule.

Ginseng also behaves as an immune modulator rather than a simple immune booster. Popular descriptions often call ginseng an "immune booster," but the laboratory picture is more interesting. Ginsenosides can enhance the activity of immune cells when a genuine threat is present while dampening the excessive, self-perpetuating inflammation that drives chronic disease. This two-way regulation, strengthening appropriate responses and calming inappropriate ones, is the hallmark of what researchers call an adaptogen. It is also why ginseng's effects on inflammation are best understood as a rebalancing of immune signaling rather than a blunt suppression of it.

What the Human Trials Show About CRP

The clearest synthesis of the human evidence comes from a 2019 meta-analysis that pooled seven randomized controlled trials. Published in Phytotherapy Research, it examined the effect of ginseng supplementation on three inflammatory markers: high-sensitivity CRP, TNF-alpha, and IL-6. The pooled results showed a significant reduction in IL-6 and a significant reduction in TNF-alpha of roughly 2.5 pg/ml, but no statistically significant change in hs-CRP overall. The authors noted that the findings were not fully robust and that longer, well-designed, dose-escalating trials were still needed (Mohammadi et al., 2019). This is an honest and useful result: ginseng moved two inflammatory cytokines but did not reliably move CRP across the whole pooled population.

A second meta-analysis found that ginseng's effect on CRP depends heavily on where people start. This review, published the same year in Complementary Therapies in Medicine, pooled nine treatment arms and found no significant effect of ginseng on CRP across all participants. But in a subgroup analysis restricted to people who began with elevated baseline CRP, ginseng produced a significant reduction of about 0.5 mg/l (Saboori et al., 2019). The pattern echoes what shows up with many anti-inflammatory interventions: when inflammation is already normal, there is little room to push it lower, but when it is elevated, the same compound has something to work on.

Put together, the two meta-analyses tell a consistent story. Ginseng's anti-inflammatory signal is real but selective. It shows up most clearly in cytokines like IL-6 and TNF-alpha, which sit upstream of CRP in the inflammatory cascade, and it shows up in CRP mainly among people whose levels are elevated to begin with. For a generally healthy person with a normal CRP, ginseng is unlikely to produce a dramatic change on a single reading. For someone carrying a higher inflammatory load, the odds of a measurable effect are better, though still modest compared with the biggest lifestyle levers.

Ginseng, Metabolic Health, and Immune Balance

Some of the most detailed human data come from trials in people with metabolic problems, where inflammation runs higher. In a randomized, double-blind, placebo-controlled study published in Complementary Therapies in Medicine, 62 men with metabolic syndrome took 3 grams per day of Korean red ginseng or placebo for four weeks. The ginseng group showed significant improvements in mitochondrial function, a rise in total testosterone and IGF-1, and reductions in diastolic blood pressure and the stress hormone cortisol compared with placebo (Jung et al., 2015). Inflammatory markers were tracked as part of the study, and the broader finding was that red ginseng favorably shifted several of the metabolic and hormonal factors that tend to travel alongside chronic low-grade inflammation.

The metabolic angle matters because inflammation rarely exists in isolation. Conditions like metabolic syndrome, insulin resistance, and excess visceral fat all generate inflammatory signaling, and they feed back on each other. An intervention that improves insulin sensitivity or reduces metabolic stress can lower inflammation indirectly, even if it is not a dedicated anti-inflammatory drug. Part of ginseng's appeal in this research is that it appears to act on several of these connected systems at once, which fits its traditional use as a general tonic rather than a targeted remedy for a single symptom.

Asian, American, and Red Ginseng: Do They Differ?

Not all ginseng is the same plant, and the differences are not just marketing. Asian or Korean ginseng (Panax ginseng) is traditionally considered more stimulating and "warming," while American ginseng (Panax quinquefolius) is regarded as more calming and "cooling." These traditional distinctions correspond to real differences in ginsenoside content. The two species contain overlapping but differently weighted mixtures of ginsenosides, which can translate into different effects on energy, blood sugar, and immune signaling. A supplement labeled simply "ginseng" could be either, so the species on the label genuinely matters.

Red ginseng is not a separate species but a different preparation. Red ginseng is made by steaming and drying the root, a process that converts some of the native ginsenosides into other forms, including compounds like Rg3 that are less abundant in the raw "white" root. Several of the human trials showing favorable effects used red ginseng specifically, so a product's processing method is part of what determines its biological activity. One important caution for research readers is that products marketed as "Siberian ginseng" (eleuthero) are not true Panax ginseng at all and contain entirely different compounds, so findings about Panax ginseng do not transfer to them.

Dose, Form, and Practical Considerations

The doses used in trials vary widely, which is one reason the evidence is harder to pin down than for a standardized drug. Human studies have used anywhere from about 1 to 3 grams of ginseng root or extract per day, often standardized to a particular percentage of ginsenosides, and the metabolic syndrome trial described above used 3 grams per day of red ginseng. Because ginsenoside content differs so much between products, the dose on the label is only a rough guide to the actual active compounds delivered. Standardized extracts that state their ginsenoside percentage give a more consistent exposure than raw powdered root of unknown potency.

Ginseng is usually taken for weeks, not days, and benefits in trials emerged over that kind of timeframe. As with most anti-inflammatory interventions, the studies that measured changes in inflammatory markers ran for four weeks or longer. Ginseng is also traditionally cycled, with some users taking breaks after a few weeks, partly to avoid the overstimulation and sleep disruption that higher doses of Asian ginseng can cause in sensitive people. There is no single universally agreed protocol, which again reflects the gap between ginseng's long history of use and the relatively recent, still-maturing body of controlled research.

How Ginseng Compares with Other Anti-Inflammatory Supplements

Ginseng sits in a middle tier of supplement evidence for inflammation. Compounds like omega-3 fatty acids and curcumin have larger, more consistent trial bases specifically targeting CRP, and their anti-inflammatory effects are better established. Ginseng's evidence is real but more selective, stronger for cytokines like IL-6 and TNF-alpha than for CRP, and complicated by the variability between products. What distinguishes ginseng is its breadth: rather than acting narrowly, it influences inflammatory signaling, metabolic function, and the stress response together, which is consistent with its classification as an adaptogen alongside herbs like ashwagandha.

As always, it helps to keep the magnitude in perspective. The changes in inflammatory markers reported in ginseng trials are statistically meaningful but modest next to the biggest levers available to most people. Losing excess body fat, exercising regularly, improving sleep, and cutting back on ultra-processed foods and alcohol typically move CRP more than any single herb. Ginseng is best viewed as one potential supporting element within that larger picture, more likely to matter for people who already have elevated inflammation or metabolic issues than for healthy adults with normal markers.

Safety and Who Should Be Cautious

Ginseng is generally well tolerated, but it is not free of interactions. The most common side effects of Asian ginseng are related to overstimulation: trouble sleeping, jitteriness, headaches, or digestive upset, especially at higher doses. More importantly, ginseng can interact with several classes of medication. It may affect blood sugar, which matters for people taking diabetes medication, and it has been reported to interact with blood thinners such as warfarin. Ginseng can also interact with stimulants and with some antidepressants.

A few groups should be more cautious and talk with a healthcare provider first. People taking anticoagulants, diabetes medications, or drugs for blood pressure should get medical advice before adding ginseng, because of the potential for additive or interfering effects. Pregnant and breastfeeding individuals have limited safety data and are generally advised to avoid supplemental ginseng. Anyone with a hormone-sensitive condition should also seek guidance, since some ginsenosides have weak hormone-like activity. As with any supplement, ginseng should complement, not replace, medically guided care of any underlying condition.

What This Means for Tracking Inflammation

Because ginseng's effect on CRP is selective and modest, the practical value lies in watching your own trend rather than expecting a single dramatic shift. If you add ginseng as part of a broader anti-inflammatory routine, tracking your CRP over the course of several weeks gives you a far clearer signal than any one-time reading. This is especially true for ginseng, where the research suggests the people most likely to see a change are those who start with elevated inflammation. A trend line built from several readings over time can show whether your overall approach, of which ginseng might be one part, is actually bending your inflammation downward.

CRP is a general wellness marker, not a disease diagnostic, and persistent elevations are always worth discussing with a healthcare provider. Ginseng is one of many traditional remedies now being held to the standard of controlled evidence, and on inflammation it comes out as genuinely but partially supported: clear effects on some cytokines, a more conditional effect on CRP, and a safety profile that is favorable for most but not all adults. For the right person, especially someone with higher baseline inflammation or metabolic concerns, a standardized ginseng product can be a reasonable addition to a lifestyle built around managing inflammation, with the understanding that it is a supporting player rather than a cure-all, despite its ancient reputation.

Sources

  • Mohammadi H, Hadi A, Kord-Varkaneh H, et al. Effects of ginseng supplementation on selected markers of inflammation: A systematic review and meta-analysis. Phytotherapy Research. 2019. pubmed.ncbi.nlm.nih.gov/31161680
  • Saboori S, Falahi E, Yousefi Rad E, Asbaghi O, Khosroshahi MZ. Effects of ginseng on C-reactive protein level: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Medicine. 2019. pubmed.ncbi.nlm.nih.gov/31331589
  • Jung DH, Lee YJ, Kim CB, Kim JY, Shin SH, Park JK. Effects of ginseng on peripheral blood mitochondrial DNA copy number and hormones in men with metabolic syndrome: A randomized clinical and pilot study. Complementary Therapies in Medicine. 2015. pubmed.ncbi.nlm.nih.gov/26860800
  • Jung DH, Nahar J, Mathiyalagan R, et al. A Focused Review on Molecular Signalling Mechanisms of Ginsenosides Anti-Lung Cancer and Anti-inflammatory Activities. Anti-Cancer Agents in Medicinal Chemistry. 2023. pubmed.ncbi.nlm.nih.gov/35319393
Share this article

Frequently Asked Questions

Does ginseng reduce inflammation?

Partly. Ginseng contains ginsenosides that suppress inflammatory signaling, and a 2019 meta-analysis of seven randomized trials found ginseng significantly lowered IL-6 and TNF-alpha but did not significantly change CRP overall. A separate meta-analysis found ginseng reduced CRP mainly in people who started with elevated levels. So ginseng has a real but selective anti-inflammatory effect, clearest on cytokines and most visible in people whose inflammation is already high.

Which type of ginseng is best for inflammation?

Most human inflammation research has used Asian or Korean ginseng (Panax ginseng), including red ginseng, which is steamed and dried to shift its ginsenoside profile. American ginseng (Panax quinquefolius) contains a different mix of ginsenosides and is traditionally considered more calming. Products labeled "Siberian ginseng" (eleuthero) are not true Panax ginseng and contain different compounds, so the research on Panax ginseng does not apply to them.

How much ginseng do studies use?

Human trials have used roughly 1 to 3 grams of ginseng root or extract per day, often standardized to a set percentage of ginsenosides, over periods of four weeks or longer. Because ginsenoside content varies widely between products, standardized extracts give a more consistent dose than raw powdered root. There is no single agreed protocol, and ginseng is often cycled with breaks to avoid overstimulation.

Is ginseng safe to take?

Ginseng is generally well tolerated, but higher doses of Asian ginseng can cause insomnia, jitteriness, or digestive upset. More importantly, it can interact with blood thinners such as warfarin, with diabetes and blood pressure medications, and with stimulants and some antidepressants. Pregnant and breastfeeding individuals and people with hormone-sensitive conditions should avoid it or consult a healthcare provider first.

Want to track your inflammation as part of a healthy lifestyle?

Sensa is a general wellness tool that lets you measure your CRP levels at home. No needles, no clinic visit. Track trends over time and make more informed lifestyle choices.

Buy Now

Get inflammation insights in your inbox

New articles on inflammation science, plus updates on the Sensa at-home CRP test and app.